CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2005-09-27 | COX MARSHALL G Director | Option exercise · Employee Stock Option (right to buy) | −46,876 | 410,000 | ||
| 2005-09-27 | COX MARSHALL G Director | Option exercise · Common Stock Warrants (right to buy) | −11,000 | 0 | ||
| 2005-09-27 | COX MARSHALL G Director | Option exercise · Common Stock Warrants (right to buy) | −5,556 | 0 | ||
| 2005-09-27 | COX MARSHALL G Director | Option exercise · Common Stock Warrants (right to buy) | −5,667 | 0 | ||
| 2005-06-28 | Milstein Alexander M Vice President- Clinical Resea | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2005-02-15 | HAWRAN PAUL W Director | Grant or award · Employee Stock Option (Right To Buy) | +50,000 | 50,000 | ||
| 2005-02-15 | Arm Douglas M Vice President Biologics Devel | Grant or award · Employee Stock Option (Right To Buy) | +50,000 | 50,000 | ||
| 2005-02-02 | Saad Mark E Chief Financial Officer | Grant or award · Employee Stock Options (Right To Buy) | +70,000 | 260,000 | ||
| 2005-02-02 | HOLMES E CARMACK Director | Grant or award · Employee Stock Options (Right To Buy) | +35,000 | 120,000 | ||
| 2005-02-02 | COX MARSHALL G Director | Grant or award · Employee Stock Option (Right To Buy) | +50,000 | 456,876 | ||
| 2005-02-02 | GALETTO CHARLES Sr. Vice President Finance & A | Grant or award · Employee Stock Options (Right To Buy) | +35,000 | 245,000 | ||
| 2005-02-02 | REUTER BRUCE Sr. Vice President Business De | Grant or award · Employee Stock Options (Right To Buy) | +35,000 | 260,000 | ||
| 2005-02-02 | SCARBROUGH ELIZABETH Vice President Marketing & Dev | Grant or award · Employee Stock Option (Right To Buy) | +35,000 | 141,250 | ||
| 2005-02-02 | SCHULZKI SHARON Chief Operating Officer | Grant or award · Employee Stock Options | +70,000 | 380,000 | ||
| 2005-02-02 | FRASER JOHN K Vice President Research & Tech | Grant or award · Employee Stock Options (Right To Buy) | +35,000 | 166,250 | ||
| 2005-02-02 | HEDRICK MARC H President | Grant or award · Employee Stock Options (Right To Buy) | +70,000 | 295,000 | ||
| 2005-02-02 | HENRIKSEN RONALD D Director | Grant or award · Employee Stock Options (Right To Buy) | +35,000 | 170,000 | ||
| 2005-02-02 | RICKEY DAVID Director | Grant or award · Employee Stock Options (Right To Buy) | +35,000 | 145,000 | ||
| 2005-02-02 | CALHOUN CHRISTOPHER J Chief Executive Officer | Grant or award · Employee Stock Option (Right To Buy) | +100,000 | 998,750 | ||
| 2004-11-18 | Saad Mark E Chief Financial Officer | Purchase | +50,000 | $3.00 | $150K | 50,000 |
Page 52 of 53 · 1,048 trades